David D. Muth
Keine laufenden Positionen mehr
Profil
David D.
Muth formerly worked at Osmotica Pharmaceutical Corp., as President & Chief Executive Officer from 2004 to 2006, Nabi Biopharmaceuticals, as Vice President-Business Operations, Cengent Therapeutics, Inc., as President & Chief Operating Officer from 2001 to 2004, Catalyst Pharmaceuticals, Inc., as Executive Vice President-Corporate Development, Structural Bioinformatics, Inc., as President & Chief Operating Officer, and Avalon Pharmaceuticals, Inc., as Chief Business Officer & Executive Vice President from 2006 to 2008.
Mr. Muth received his Masters Business Admin degree from Fairleigh Dickinson University, Masters Business Admin degree from Pace University, and undergraduate degree from Villanova University.
Ehemalige bekannte Positionen von David D. Muth
| Unternehmen | Position | Ende |
|---|---|---|
Avalon Pharmaceuticals, Inc.
 Avalon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avalon Pharmaceuticals, Inc. was a biopharmaceutical company focused on the discovery, development and commercialization of cancer therapeutics. The company was founded in November 1999 and headquartered in Germantown, MD. | Corporate Officer/Principal | 20.02.2008 |
Osmotica Pharmaceutical Corp.
 Osmotica Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Osmotica Pharmaceutical Corp. provides drug delivery technologies and neurology based therapies. It develops and commercializes a portfolio of products related to central nervous system disorders with a focus in Parkinson's disease and related neurological disorders. The company was founded in 1986 and is headquartered in Bridgewater, GA. | Präsident | 01.01.2006 |
Cengent Therapeutics, Inc.
 Cengent Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cengent Therapeutics, Inc. used to research and develop pharmaceutical drugs. It was a structure-based drug discovery company with a primary focus on compounds targeting signal transduction for the treatment of obesity and diabetes. It used to discover orally active PTP-1B inhibitors for treatment of type II diabetes and obesity. It was headquartered in San Diego, CA. | Präsident | 01.01.2004 |
| CATALYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Nabi Biopharmaceuticals
 Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Corporate Officer/Principal | - |
Ausbildung von David D. Muth
| Villanova University | Undergraduate Degree |
| Pace University | Masters Business Admin |
| Fairleigh Dickinson University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CATALYST PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Avalon Pharmaceuticals, Inc.
Avalon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avalon Pharmaceuticals, Inc. was a biopharmaceutical company focused on the discovery, development and commercialization of cancer therapeutics. The company was founded in November 1999 and headquartered in Germantown, MD. | Health Technology |
Osmotica Pharmaceutical Corp.
Osmotica Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Osmotica Pharmaceutical Corp. provides drug delivery technologies and neurology based therapies. It develops and commercializes a portfolio of products related to central nervous system disorders with a focus in Parkinson's disease and related neurological disorders. The company was founded in 1986 and is headquartered in Bridgewater, GA. | Health Technology |
Cengent Therapeutics, Inc.
Cengent Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cengent Therapeutics, Inc. used to research and develop pharmaceutical drugs. It was a structure-based drug discovery company with a primary focus on compounds targeting signal transduction for the treatment of obesity and diabetes. It used to discover orally active PTP-1B inhibitors for treatment of type II diabetes and obesity. It was headquartered in San Diego, CA. | Commercial Services |
Structural Bioinformatics, Inc.
 Structural Bioinformatics, Inc. Pharmaceuticals: MajorHealth Technology Structural Bioinformatics, Inc. researches proteomics and discovers drugs using genomic sequences. | Health Technology |
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Health Technology |
